Tumor cell killing mechanisms of epidermal growth factor receptor (EGFR) antibodies are not affected by lung cancer-associated EGFR kinase mutations.
Publication date
2008
Authors
Peipp, M.
Schneider-Merck, T.
Dechant, M.
Beyer, T.
Lammerts van Bueren, J.J.
Bleeker, W.K.
Parren, P.W.H.I.
Van De Winkel, Jan G.J.
Valerius, T.
Editors
Advisors
Supervisors
DOI
Document Type
Article
Metadata
Show full item recordCollections
License
Abstract
Keywords
Citation
Peipp, M, Schneider-Merck, T, Dechant, M, Beyer, T, Lammerts van Bueren, J J, Bleeker, W K, Parren, P W H I, van de Winkel, J G J & Valerius, T 2008, 'Tumor cell killing mechanisms of epidermal growth factor receptor (EGFR) antibodies are not affected by lung cancer-associated EGFR kinase mutations.', Journal of Immunology, vol. 180, no. 6, pp. 4338-4345.